Buy Exact Sciences Stock EXAS Stock Price Today & News

The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Exact Sciences is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Reports record revenue, expects revenue of $2,265-2,315 million and positive adjusted EBITDA for full year 2023 Fourth quarter and 2022 highlights Total fourth quarter revenue of $553 million, an inc… This form of medicine based on the particular genes, proteins, and other substances in a person’s body.

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Enterprise Value is a measure of a company’s total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company’s balance sheet. Market cap or market capitalization is the total market value of all of a company’s outstanding shares.

High institutional ownership can be a signal of strong market trust in this company. In the past three months, Exact Sciences insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,922,776.00 in company stock. MarketBeat has tracked 8 news articles for Exact Sciences this week, compared to 5 articles on an average week. Exact Sciences has a short interest ratio (“days to cover”) of 5.7.

The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies. The company’s average rating score is 2.67, and is based on 8 buy ratings, 4 hold ratings, and no sell ratings. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market.

Our Services

It’s certainly not easy to find millionaire-maker stocks if you only have $50,000 or less to invest. In order to turn that amount of money into $1 million using a single stock, you’ll need vision, a c… As the founder and CEO of the investment management firm ARK Invest, she has an investment philosophy that focuses on innovative technologies an… Provide specific products and services to you, such as portfolio management or data aggregation. CompareEXAS’s historical performanceagainst its industry peers and the overall market.

• None of these entities provide legal, tax, or accounting advice.
• This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system.
• Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

The price-to-book ratio is a company’s current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

NewsExact Sciences Corp.EXAS

The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.

Analyst Ratings

Notable companies to have witnessed solid earnings acceleration as of now are ColgatePalmolive , BigCommerce & Exact Sciences . Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services.

A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The price-earnings ratio is a company’s share price to the company’s Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.

FTC Challenge of Illumina’s Cancer-Screening Acquisition Rejected by Judge

In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of (“Regulation A”).

Transparency is how we protect the integrity of our work and keep empowering guaranteed minimal incomeors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of EXAS’s competitive advantage. There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

About EXAS

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. If you’re new to stock investing, here’s how to buy Exact Sciences stock. Overall, this stock passed 7/33 due dilligence checks and has weak fundamentals, according to our automated analysis. There may be delays, omissions, or inaccuracies in the Information.

Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. Sign-up to receive the latest news and ratings for Exact Sciences and its competitors with MarketBeat’s FREE daily newsletter. 90.30% of the stock of Exact Sciences is held by institutions.

Exact Sciences’ stock was trading at $49.51 on January 1st, 2023. Since then, EXAS stock has increased by 29.4% and is now trading at $64.07. Exact Sciences has received a 77.54% net impact score from Upright. The largest positive contribution comes from its “Physical diseases” impact, which is driven by its “Private colorectal cancer diagnostics services” product. 6.38% of the outstanding shares of Exact Sciences have been sold short.

The https://1investing.in/ly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Exact Sciences’s market cap is calculated by multiplying EXAS’s current stock price of $64.07 by EXAS’s total outstanding shares of 178,217,142. 12 Wall Street research analysts have issued 12 month price objectives for Exact Sciences’ stock.

Gear advertisements and other marketing efforts towards your interests. We’d like to share more about how we work and what drives our day-to-day business. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Exact Sciences does not have a long track record of dividend growth. Short interest in Exact Sciences has recently decreased by 2.71%, indicating that investor sentiment is improving.

Discuss news and analysts’ price predictions with the investor community. Intraday Data provided by FACTSET and subject to terms of use. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

What analysts recommend for EXAS stock, on a scale from 1 to 5. David Jagielski | Feb 3, 2023 The stock is full of potential — and risk. Upgrade to MarketBeat All Access to add more stocks to your watchlist. One share of EXAS stock can currently be purchased for approximately $64.07.